IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q2 2023 Holdings

Filed 2023-08-10 | 3 holdings | $4.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Werewolf Therapeutics Inc(HOWL)COM95075A107$1.8M589,10238.3%
Tscan Therapeutics Inc(TCRX)COM89854M101$1.6M630,00033.5%
Vaccitech PLC(BRNS)ADS91864C107$1.3M642,20428.2%